BUFFALO, N.Y. -- A nasal spray shown to numb the upper jaw is set to be tested in an FDA Phase 3 trial, which will assess the spray's effectiveness compared to the current "gold standard" treatment -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback